Postapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the US | Infectious Diseases | JN Learning | AMA Ed Hub [Skip to Content]
[Skip to Content Landing]

Postapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the US

Educational Objective
To identify the key insights or developments described in this article
1 Credit CME

Since January 2020, more than 7.8 million cases of coronavirus disease 2019 (COVID-19) and 215 000 deaths have occurred in the US. In response to the pandemic, vaccine development has been moving at record speed through strong public or private partnerships, with nearly 200 vaccine candidates in development or in trials. In the US, 8 vaccine candidates have received federal support under Operation Warp Speed, and 4—from Moderna, Pfizer/BioNTech, Oxford/AstraZeneca, and Janssen—have entered phase 3 trials. Vaccines will be critical for the prevention and control of COVID-19 in the US and worldwide, yet these efforts cannot succeed without public confidence in a vaccination program. Demonstrating vaccine efficacy and safety during clinical trials and implementing a robust postlicensure vaccine safety monitoring system as the vaccine is deployed in larger, more diverse populations is central to public confidence and enabling timely and accurate policy decisions for population-level use.

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

Article Information

Corresponding Author: Grace M. Lee, MD, MPH, Stanford University School of Medicine, 300 Pasteur Dr, H306-A, Stanford, CA 94305 (gmlee@stanfordchildrens.org).

Published Online: October 16, 2020. doi:10.1001/jama.2020.19692

Conflict of Interest Disclosures: Drs Lee, Bell, and Romero reported that they are members of the Advisory Committee on Immunization Practices. No other disclosures were reported.

References
1.
Salmon  DA , Akhtar  A , Mergler  MJ ,  et al.  Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program.   Pediatrics. 2011;127(suppl 1):S78-S86.PubMedGoogle ScholarCrossref
2.
Lurie  N , Sharfstein  JM , Goodman  JL .  The development of COVID-19 vaccines: safeguards needed.   JAMA. 2020;324(5):439-440.PubMedGoogle ScholarCrossref
3.
Shimabukuro  TT , Nguyen  M , Martin  D , DeStefano  F .  Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).   Vaccine. 2015;33(36):4398-4405.PubMedGoogle ScholarCrossref
4.
Centers for Disease Control and Prevention (CDC).  Intussusception among recipients of rotavirus vaccine—United States, 1998-1999.   MMWR Morb Mortal Wkly Rep. 1999;48(27):577-581.PubMedGoogle Scholar
5.
Shah  A , Marks  PW , Hahn  SM .  Unwavering regulatory safeguards for COVID-19 vaccines.   JAMA. 2020;324(10):931-932. doi:10.1001/jama.2020.15725PubMedGoogle ScholarCrossref
6.
Yih  WK , Kulldorff  M , Fireman  BH ,  et al.  Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project.   Pediatrics. 2011;127(suppl 1):S54-S64. doi:10.1542/peds.2010-1722IPubMedGoogle ScholarCrossref
7.
Bauchner  H , Malani  PN , Sharfstein  J .  Reassuring the public and clinical community about the scientific review and approval of a COVID-19 vaccine.   JAMA. 2020;324(13):1296-1297.PubMedGoogle ScholarCrossref
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_LoginSubscribe_Purchase
Close
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_LoginSubscribe_Purchase
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
Close
With a personal account, you can:
  • Track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
jn-learning_Modal_SaveSearch_NoAccess_Purchase
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close